Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal aberrations in human neuroblastomas

G M Brodeur, G Sekhon, M N Goldstein

    Cancer
    |November 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The impact of socioeconomic determinants of health and resulting health inequalities on children and young people with long-term health conditions in the UK: a scoping review protocol.

    Systematic reviews·2025
    Same author

    An antenatal diagnosis: Congenital high airway obstruction.

    Annals of cardiac anaesthesia·2017
    Same author

    Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.

    British journal of cancer·2012
    Same author

    International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    British journal of cancer·2009
    Same author

    Molecular analysis of gene amplification in tumors.

    Current protocols in human genetics·2008
    Same author

    Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.

    Oncogene·2007
    Same journal

    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

    Cancer·2026
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    See all related articles

    A consistent chromosomal abnormality, a 1p-deletion, was identified in human neuroblastomas. This finding may help explain the origins of childhood cancer and the development of malignant behavior.

    Area of Science:

    • Cytogenetics
    • Pediatric Oncology
    • Cancer Genetics

    Background:

    • Neuroblastoma is a common pediatric cancer originating from immature nerve cells.
    • Understanding the genetic basis of neuroblastoma is crucial for developing targeted therapies.
    • Previous studies have suggested various chromosomal abnormalities in neuroblastoma, but a consistent marker has been elusive.

    Purpose of the Study:

    • To identify consistent chromosomal aberrations in human neuroblastoma tumors and cell lines.
    • To investigate the potential role of specific chromosomal changes in neuroblastoma development.
    • To correlate cytogenetic findings with existing hypotheses on childhood cancer etiology.

    Main Methods:

    • Analysis of six human neuroblastoma samples, including two primary tumors and four established cell lines.

    Related Experiment Videos

  • Application of Giemsa and fluorescence banding techniques for detailed chromosomal analysis.
  • Karyotyping to identify numerical and structural chromosomal abnormalities.

    • Main Results:

    • Five of the six neuroblastomas were diploid or near-diploid; one was near-tetraploid.
    • A deletion on the short arm of chromosome 1 (1p-) was the most consistent abnormality, found in three of the six samples.
    • This 1p-deletion was present in both primary tumors and in one established cell line, sometimes as the sole detected abnormality.
    • Giant marker chromosomes were observed in cell lines, but double-minute chromosomes were absent.

    Conclusions:

    • The 1p-deletion is a recurring chromosomal abnormality in human neuroblastomas.
    • This specific deletion may be significant in the pathogenesis of neuroblastoma.
    • Further research on primary tumors is needed to confirm the link between 1p-deletion and malignant progression.